Home Compare COR vs GALE.SW
Stock Comparison · Industry comparison · Medical Distribution

Cencora vs Galenica: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Cencora carrying a narrow edge on profitability. The remaining gap is narrow enough that the comparison remains open to different readings. The market setup is currently leaning toward Galenica, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Cencora, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The comparison is mainly decided in profitability, with the rest of the profile carrying less weight.

INDUSTRY COMPARISON

Both operate in: Medical Distribution

This comparison is based on industry proximity, not on functional trajectory similarity. COR and GALE.SW share the same industry classification.

For a similarity-based comparison, see how Cencora and Galenica each position within their functional peer groups in AssetNext.

Peer-Relative Score
COR
Cencora, Inc.
53
Peer-Score
Signal qualityMedium
vs
GALE.SW
Galenica AG
48
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in profitability.

Dimension spread: COR vs GALE.SW Profitability 64 43 Stability 77 79 Valuation 45 54 Growth 22 17 COR GALE.SW
Gap Ranking
#1 Profitability +21
#2 Valuation +9
#3 Growth +5
#4 Stability +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for COR and GALE.SW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer CORGALE.SW Relative valuation Structural strength

The setup splits cleanly: structure favours Cencora, Inc., while the price setup favours Galenica AG.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Both rank well on profitability, but Cencora, Inc. still sits higher.
Valuation
On valuation, the same pattern holds: both rank well, but Galenica AG still sits higher.
Profitability — Dominant Gap
COR
64
GALE.SW
43
Gap+21in favour of COR

Capital efficiency adds support, with a 10.4-point ROIC advantage.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Galenica, with a trailing P/E that is 13.8 turns lower there.

What this means for the comparison

Profitability is the clearest driver, and valuation also supports Cencora, Inc.'s broader structural position.

Explore full peer positioning in AssetNext

Break down the COR vs GALE.SW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-valuation comparisons

Explore how COR and GALE.SW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.